Key result
Plasma 25(OH)D levels <12 ng/ml in ICU patients were associated with a significantly higher risk of major adverse events (HR 4.47; 95% CI 1.77-11.3; p=0.020).
Why the study?
ICU patients are at high risk of unfavorable outcomes, and vitamin D deficiency may affect these outcomes given its role in cardiovascular and immune functions.
Do low plasma 25-hydroxyvitamin D levels (<12 ng/ml) at admission predict major adverse events in ICU patients?
Cohort (n=169)
Do low plasma 25-hydroxyvitamin D levels (<12 ng/ml) at admission predict major adverse events in ICU patients?
Hazard Ratio: 4.47 (95% CI 1.77–11.3)
p-value: p=.020
Low plasma 25-hydroxyvitamin D levels (<12 ng/ml) at admission are associated with a significantly increased risk of major adverse events and ICU-acquired infections in ICU patients.
Low vitamin D may flag higher-risk ICU patients for monitoring; leaves open whether repletion reduces events in trials.
Introduction: Patients in intensive care units (ICUs) are at high risk of unfavorable outcomes. Considering the role of vitamin D (Vit D) in cardiovascular and immune functions, Vit D deficiency could affect ICU patients’ outcomes. This study aimed to evaluate Vit D status and its predictive value for outcome in ICU patients. Patients and Methods: A total of 169 ICU patients were followed during ICU stay. Primary outcome was the occurrence of at least one major adverse event; secondary outcomes were organ failure, septic shock, ICU-acquired infection, other adverse events, and ICU mortality. Plasma 25-hydroxyvitamin D (25(OH)D) was assessed by immunoassay. Multivariate Cox regression analyses were performed to test the associations of low 25(OH)D levels with poor outcomes. Results: Around 75% of patients had 25(OH)D levels <12 ng/ml. During their ICU stay, 114 patients experienced a major adverse event, 85 patients presented an ICU-acquired infection, and 22 patients died. Plasma 25(OH)D levels <12 ng/ml were associated with higher risk of major adverse events, Hazard ratio [95% CI], 4.47 [1.77, 11.3], p = .020, and ICU-acquired infection, 2.67 [1.01, 7.42], p = .049, but not with increased risk of ICU mortality. Conclusions: Hypovitaminosis D is very common in ICU patients. Results of the present study show that low plasma 25(OH)D levels are associated with increased risk of unfavorable outcomes in these patients. Additional research is needed to investigate the impact of Vit D status and effect of Vit D supplementation in ICU patients.
No takes yet. Share an insight, caveat, or question.
Maamer et al. (2020) conducted a cohort in Intensive care unit patients (n=169). Plasma 25-hydroxyvitamin D levels <12 ng/ml vs. Plasma 25-hydroxyvitamin D levels ≥12 ng/ml was evaluated on Occurrence of at least one major adverse event (HR 4.47, 95% CI 1.77, 11.3, p=.020). Plasma 25(OH)D levels <12 ng/ml in ICU patients were associated with a significantly higher risk of major adverse events (HR 4.47; 95% CI 1.77-11.3; p=0.020).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: